American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$263M |
| 2 |
Church & Dwight Co
CHD
|
+$176M |
| 3 |
Lattice Semiconductor
LSCC
|
+$159M |
| 4 |
UnitedHealth
UNH
|
+$159M |
| 5 |
Meta Platforms (Facebook)
META
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$314M |
| 2 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$243M |
| 3 |
Air Products & Chemicals
APD
|
+$201M |
| 4 |
HES
Hess
HES
|
+$194M |
| 5 |
Visa
V
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.39% |
| 2 | Financials | 13.48% |
| 3 | Healthcare | 12.47% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Lyell Immunopharma
LYEL
$337M
| $282K | ﹤0.01% |
7,272
+1,224
| +20% | +$44.1K |
|
2552
Joby Aviation
JOBY
$8.17B
| $282K | ﹤0.01% |
42,376
-171
| -0.4% | -$1.05K |
|
|
TRML
2553
DELISTED
Tourmaline Bio
TRML
| $282K | ﹤0.01% |
+10,761
| New | +$215K |
|
2554
SEACOR Marine Holdings
SMHI
$262M
| $281K | ﹤0.01% |
+22,356
| New | +$286K |
|
2555
Boston Omaha
BOC
$431M
| $280K | ﹤0.01% |
17,797
+2,431
| +16% | +$36.9K |
|
|
MODN
2556
DELISTED
MODEL N, INC.
MODN
| $279K | ﹤0.01% |
10,375
-3,281
| -24% | -$79K |
|
2557
Carriage Services
CSV
$555M
| $278K | ﹤0.01% |
11,127
+3,750
| +51% | +$88.3K |
|
2558
Sotera Health
SHC
$5.43B
| $277K | ﹤0.01% |
16,453
| – | – |
|
2559
Replimune Group
REPL
$1.42B
| $277K | ﹤0.01% |
32,866
+2,417
| +8% | +$28K |
|
2560
ESAB
ESAB
$5.29B
| $277K | ﹤0.01% |
3,197
-176,464
| -98% | -$13.4M |
|
2561
Novanta
NOVT
$6.33B
| $275K | ﹤0.01% |
1,631
+76
| +5% | +$11.1K |
|
|
VRE
2562
DELISTED
Veris Residential
VRE
| $275K | ﹤0.01% |
17,456
-1,964
| -10% | -$29.2K |
|
2563
Recursion Pharmaceuticals
RXRX
$1.78B
| $274K | ﹤0.01% |
27,798
-58,127
| -68% | -$414K |
|
2564
iRadimed
IRMD
$1.11B
| $271K | ﹤0.01% |
5,706
+455
| +9% | +$19.1K |
|
2565
Samsara
IOT
$24B
| $269K | ﹤0.01% |
8,060
| – | – |
|
2566
Alta Equipment Group
ALTG
$234M
| $267K | ﹤0.01% |
21,607
+5,691
| +36% | +$61.4K |
|
|
KEEL
2567
Keel Infrastructure Corp
KEEL
$2.04B
| $267K | ﹤0.01% |
91,733
-719,987
| -89% | -$1.16M |
|
2568
ARS Pharmaceuticals
SPRY
$606M
| $266K | ﹤0.01% |
48,449
-3,072
| -6% | -$13.5K |
|
2569
8x8 Inc
EGHT
$303M
| $265K | ﹤0.01% |
+70,105
| New | +$208K |
|
2570
Puma Biotechnology
PBYI
$450M
| $264K | ﹤0.01% |
+61,052
| New | +$202K |
|
|
HTT
2571
High Templar Tech Ltd
HTT
$391M
| $264K | ﹤0.01% |
129,479
+5,856
| +5% | +$11K |
|
2572
Workiva
WK
$4.01B
| $259K | ﹤0.01% |
2,554
+274
| +12% | +$26.4K |
|
|
SFIX
2573
Stitch Fix
SFIX
$487M
| $259K | ﹤0.01% |
72,561
+25,632
| +55% | +$90.4K |
|
|
TSE
2574
DELISTED
Trinseo
TSE
| $258K | ﹤0.01% |
30,815
+1,870
| +6% | +$12.5K |
|
2575
TaskUs
TASK
$667M
| $258K | ﹤0.01% |
19,709
+3,419
| +21% | +$37.9K |
|
Similar funds
American Century Companies's Q4 2023 Portfolio in Review
As of Q4 2023, American Century Companies held 2,961 positions worth $145B, up 12% from $130B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
American Century Companies's Q4 2023 filing shows 141 new, 1,802 increased, 780 reduced and 86 closed positions. Its largest new stake was Nextpower Inc: 1,286,526 shares worth $60.3M. The largest sale was Humana, an estimated $314M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- American Century Companies's largest Q4 2023 buy was Nextpower Inc: 1,286,526 shares worth $60.3M.
- American Century Companies added most to Salesforce in Q4 2023, an estimated $263M increase.
- American Century Companies's biggest Q4 2023 reduction was Humana, cutting an estimated $314M.
- American Century Companies fully exited Earthstone Energy Inc. Class A Common Stock in Q4 2023, selling an estimated $58.9M.
- American Century Companies's ten largest holdings make up 23% of its $145B portfolio in Q4 2023.
- American Century Companies opened 141 new positions and closed 86 in Q4 2023.
- American Century Companies's portfolio value rose 12% quarter-over-quarter to $145B.
Based on American Century Companies's 13F filing for Q4 2023, filed 13 Feb 2024.